Back to Search Start Over

CD8 T-cells from most HIV-infected patients lack ex vivo HIV-suppressive capacity during acute and early infection

Authors :
Lecuroux, Camille
Girault, Isabelle
Chéret, Antoine
Versmisse, Pierre
Nembot, Georges
Meyer, Laurence
Rouzioux, Christine
Pancino, Gianfranco
Venet, Alain
Saez-Cirion, Asier
trial, ANRS 147 OPTIPRIM
Régulation de la réponse immune, infection VIH-1 et autoimmunité
Université Paris-Sud - Paris 11 (UP11)-Institut National de la Santé et de la Recherche Médicale (INSERM)
Infections à Vih, Réservoirs, Pharmacologie des Antirétroviraux et Prévention de la Transmission Mère Enfant
Université Paris Descartes - Paris 5 (UPD5)
Service Universitaire de Maladies Infectieuses et du Voyageur
Centre Hospitalier Gustave Dron
Régulation des Infections Rétrovirales
Institut Pasteur [Paris]
INSERM U1018, Faculté de Médecine Paris Sud
Institut National de la Santé et de la Recherche Médicale (INSERM)
Departement d'épidémiologie
AP-HP Hôpital Bicêtre (Le Kremlin-Bicêtre)
Laboratoire de Virologie [CHU Necker]
CHU Necker - Enfants Malades [AP-HP]
Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)
The ANRS 147 OPTIPRIM trial was funded by ANRS (French National Agency for Research on AIDS and Viral Hepatitis) and conducted with the support of MSD, Janssen, ViiV Healthcare and Gilead. CL received a postdoctoral fellowship from ANRS. GP is an employee of INSERM (Institut National de la Santé et de la Recherche Médicale). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Institut Pasteur [Paris] (IP)
Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-CHU Necker - Enfants Malades [AP-HP]
Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)
Guibert, Marie-Genevieve
Université Paris-Sud - Paris 11 ( UP11 ) -Institut National de la Santé et de la Recherche Médicale ( INSERM )
Université Paris Descartes - Paris 5 ( UPD5 )
Institut National de la Santé et de la Recherche Médicale ( INSERM )
Assistance publique - Hôpitaux de Paris (AP-HP)-CHU Necker - Enfants Malades [AP-HP]
Source :
PLoS ONE, PLoS ONE, Public Library of Science, 2013, 8 (3), pp.e59767. ⟨10.1371/journal.pone.0059767⟩, PLoS ONE, 2013, 8 (3), pp.e59767. ⟨10.1371/journal.pone.0059767⟩, PLoS ONE, Vol 8, Iss 3, p e59767 (2013), PLoS ONE, Public Library of Science, 2013, 8 (3), pp.e59767. 〈10.1371/journal.pone.0059767〉
Publication Year :
2013
Publisher :
HAL CCSD, 2013.

Abstract

International audience; The strong CD8+ T-cell-mediated HIV-1-suppressive capacity found in a minority of HIV-infected patients in chronic infection is associated with spontaneous control of viremia. However, it is still unclear whether such capacities were also present earlier in the CD8+ T cells from non controller patients and then lost as a consequence of uncontrolled viral replication. We studied 50 patients with primary HIV-1-infection to determine whether strong CD8+ T-cell-mediated HIV suppression is more often observed at that time. Despite high frequencies of polyfunctional HIV-specific CD8+ T-cells and a strong CD4+ T-helper response, CD8+ T-cells from 48 patients lacked strong HIV-suppressive capacities ex vivo. This indicates that the superior HIV-suppressive capacity of CD8+ T-cells from HIV controllers is not a general characteristic of the HIV-specific CD8+ T cell response in primary HIV infection.

Details

Language :
English
ISSN :
19326203
Database :
OpenAIRE
Journal :
PLoS ONE, PLoS ONE, Public Library of Science, 2013, 8 (3), pp.e59767. ⟨10.1371/journal.pone.0059767⟩, PLoS ONE, 2013, 8 (3), pp.e59767. ⟨10.1371/journal.pone.0059767⟩, PLoS ONE, Vol 8, Iss 3, p e59767 (2013), PLoS ONE, Public Library of Science, 2013, 8 (3), pp.e59767. 〈10.1371/journal.pone.0059767〉
Accession number :
edsair.doi.dedup.....39e7d5144a93d0c4c154e548acf1f7bc
Full Text :
https://doi.org/10.1371/journal.pone.0059767⟩